Uterine Fibroid Market is expected to reach USD 39,993.2 million from 2016 to 2022

Uterine Fibroid Market Research Report – U.S. Forecast to 2022
U.S. Uterine Fibroid Market Information by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) – Forecast to 2022

Market Synopsis of U.S. Uterine Fibroid Market:

Market Scenario:

Uterine Fibroids are the abnormal growth that gets developed inside or on the wall of a woman’s uterus. These are also known as leiomyoma or myomas. These are noncancerous growths that cause symptoms such as heavy bleeding between or during the menstrual cycle, pain in pelvis or lower back, increased menstrual cramping, swelling enlargement of the abdomen. Increasing prevalence due to heredity and rising number of treatments to cure this disease has fuelled the growth of this market. 

The U.S. Market for Uterine Fibroids is expected to reach USD 39,993.2 million by the end of the forecasted period and is expected to grow at a CAGR of 3.24%.

 

Key Players for U.S.  Uterine Fibroid Market:

  • AstraZeneca (England),
  • Cook Medical Inc. (US),
  • Boston Scientific Corporation (US),
  • GE Healthcare (U.K.),
  • AbbVie Inc. (U.S.),
  • Hologic (U.S.),
  • others.

 

Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/2394

 

Key Finding

  • The U.S. Uterine Fibroid market and is expected to reach USD 39,993.2 million by 2022.
  • By Type, Intramural Fibroids holds the largest market share of U.S. uterine fibroid market and is expected to reach USD 14,972.5 million by 2022.
  • By Treatment, hysterectomy holds the largest market share of U.S. uterine fibroid market and is expected to reach USD 8,042.3 million by 2022.

 

Regional Analysis of U.S. Uterine Fibroid Market:

The U.S. market for uterine fibroids is growing steadily. The market for uterine fibroids is growing with the CAGR of 3.24% during the forecast period from 2016-2022. California, Texas, Florida, New York are some of the states which are estimated to have highest prevalence of uterine fibroids.

 

Taste the market data and market information presented through more than 50 market data tables and figures spread in 110 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Uterine Fibroid Market Research Report – U.S. Forecast to 2022

 

Access Report Detail @ https://www.marketresearchfuture.com/reports/uterine-fibroid-market

 

Table of Content

1    Introduction    8
1.1.1    Prevalence of the Uterine Fibroids in U.S.    8
2    Scope of Study    10
2.1    Research Objective    10
2.2    Assumptions & Limitations    10
2.2.1    Assumptions    10
2.2.2    Limitations    10
2.3    Market Structure    11
3    Research Methodology    12
3.1    Primary Research    13
3.2    Secondary Research    13
4    U.S. Uterine Fibroid Market    15
4.1    Introduction    15
4.2    U.S. Uterine Fibroid Market, By Type    17
4.3    U.S. Uterine Fibroid Market, By Diagnosis    19
4.4    U.S. Uterine Fibroid Market, By Treatment    21
5    Company Profile    29

Continue…………….

 

List Of Tables

Table 1    U.S. Uterine Fibroid Market, By Type, 2013-2022 (Usd Million)    18
Table 2    U.S. Uterine Fibroid Market, By Diagnosis, 2013-2022 (Usd Million)    20
Table 3    U.S. Uterine Fibroid Market, By Treatment, 2013-2022 (Usd Million)    23
Table 4    U.S. Uterine Fibroid Market, By Treatment Type, 2013-2022 (Usd Million)    24
Table 5    Pipeline Products For Uterine Fibroids    27
Table 6    Astrazeneca: Key Development    31
Table 7    Boston Scientific Corporation: Key Development    36
Table 8    Ge Healthcare: Key Development    40

Continue………….

 

List Of Figures

Figure 1    Comparison Between Diagnosis & Treatment Market, 2013-2022 (Usd Million)    9
Figure 2    U.S. Uterine Fibroid Market: Market Structure    11
Figure 3    Research Process    12
Figure 4    U.S. Uterine Fibroid Market, By Type, 2015 & 2022 (Usd Million)    18
Figure 5    U.S. Uterine Fibroid Market, By Diagnosis, 2015 & 2022 (Usd Million)    20
Figure 6    Treatments For Uterine Fibroids    22
Figure 7    U.S. Uterine Fibroid Market, By Treatment, 2013-2022 (Usd Million)    23
Figure 8    U.S. Uterine Fibroid Market, By Treatment Type, 2015 & 2022 (Usd Million)    24
Figure 9    Pharmacotherapy Treatment Forecast, 2015-2022    26
Figure 10    Astrazeneca: Recent Financial    30

Continue………..

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/uterine-fibroid-market